These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12856424)

  • 1. [Anemia in cancer patients before treatment].
    Auclerc G; Meric JB; Pommeyrol A; Rixe O; Khayat D
    Bull Cancer; 2003 Apr; 90 Spec No():S128-32. PubMed ID: 12856424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anemia impact on treatments of cervical carcinomas].
    Marchal C; Rangeard L; Brunaud C
    Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
    Mittelman M
    Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of anemia to fatigue in the cancer patient.
    Sabbatini P
    Oncology (Williston Park); 2000 Nov; 14(11A):69-71. PubMed ID: 11195421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To give or not to give recombinant EPO to anemia endangered cancer patients.
    Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
    Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cancer-related anemia.
    Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
    Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-related anemia: biological findings, clinical implications and impact on quality of life.
    Blohmer JU; Dunst J; Harrison L; Johnston P; Khayat D; Ludwig H; O'Brien M; Van Belle S; Vaupel P
    Oncology; 2005; 68 Suppl 1():12-21. PubMed ID: 15855812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPO in cancer anemia: benefits and potential risks.
    Milano M; Schneider M
    Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].
    Queipo Zaragozá JA; Chicote Pérez F; Beltrán Meseguer JF; Borrell Palanca A; Giner Marco V; Esteve Claramunt J; Pastor Sempere F
    Arch Esp Urol; 2004; 57(1):35-40. PubMed ID: 15112869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cancer-related anemia with epoetin alfa: a review.
    Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
    Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
    Harrison L; Blackwell K
    Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of serum erythropoietin detection in patients with cancer-related anemia].
    Li LB; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):954-5. PubMed ID: 13129732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rHuEPO and treatment outcomes: the clinical experience.
    Hudis CA; Van Belle S; Chang J; Muenstedt K
    Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blue cross blue shield assessment technology review: summary of findings.
    Bennett CL
    Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia in multiple myeloma.
    Ludwig H; Pohl G; Osterborg A
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO).
    Burk R
    Med Hypotheses; 2007; 69(6):1200-4. PubMed ID: 17493766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
    Desai J; Demetri GD
    Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of anemia and fatigue on quality of life in cancer patients: a brief review.
    Thomas ML
    Med Oncol; 1998 Aug; 15 Suppl 1():S3-7. PubMed ID: 9785330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.